Atlas FDA

EL-aCL Anti-Cardiolipin ELISA Kit; an in-vitro diagnostic anticardiolipin immunological test system; 192 tests per kit;

FDA device recall Z-0835-06 · posted 2006-05-04 · Terminated

Recall details

Recalling firm
Thera Test Laboratories, Inc.
Reason for recall
The specimen diluent contained in the kits was contaminated with a fungal growth. Also, a portion of kit lot 09055514 was shipped without the Data Sheet, part #201-204.
Action taken
On 10/26/05, Thera Test telephoned the 3 accounts who received lot 09055514 without the Data Sheet in the kits, and sent them copies of the Data Sheet for insertion into the 6 kits on hand at the consignees. Between 1/4-9/06, Thera Test telephoned the 17 accounts receiving kit lots 09055514 and 12055603, and sent them follow-up letters dated 1/9/06 with replacement bottles of Specimen Diluent. The accounts were advised of the fungal contamination found in some bottles of the diluent shipped with the kit lots, and were requested to destroy any remaining bottles of the Specimen Diluent in their kits and replace them with the bottles of diluent sent with the letter.
Root cause
Other
Status
Terminated
Product code
MID
Quantity affected
53 kits
Distribution
California, Connecticut, Maryland, Pennsylvania, Ohio, New Jersey and Florida.
Date initiated
2006-01-11
Date posted
2006-05-04
Date terminated
2006-05-03
Location
Lombard, IL

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
EL-ACL SCREEN; EL-ACL IGM, IGG, IGA (K060176)Theratest Laboratories, Inc.2006-02-07